# The Minimum Effective Concentration of Lidocaine for Ultrasound-guided Axillary Block for Arterio-venous Fistula Creation Surgery

> **NCT05063578** · NA · UNKNOWN · sponsor: **Far Eastern Memorial Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** Lidocaine 2% Injectable Solution

## Key facts

- **NCT ID:** NCT05063578
- **Lead sponsor:** Far Eastern Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-20
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05063578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05063578, "The Minimum Effective Concentration of Lidocaine for Ultrasound-guided Axillary Block for Arterio-venous Fistula Creation Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05063578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*